Drawing for BIODESIX

USPTO serial 98904809

BIODESIX

Reviewed by CopyMark Law Group

Reg. 8382713Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
JACKSON, SHA-KARA ELOUISE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIODESIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina Brown

Christina Brown GrowIP Law Group LLC117 S. Cook St. #359Barrington, IL 60010United States

Goods and services

ClassDescriptionStatusFirst use
010Medical testing kit comprised primarily of blood collecting tubes and bags, holder for medical sample tubes, vials and desiccant for testing blood for assessing the likelihood of patient outcomes and medical treatments; medical diagnostic apparatus for testing biological specimens, namely, molecular diagnostic tests which use molecular tools, mass spectrometry, enzyme-linked immunosorbent assays and algorithms to test biological specimens for the presence of biomarkers, to assist  in assessing the likelihood of malignancy.ACTIVE—
044Diagnostic testing services that may be ordered by health care providers to provide information for medical treatment or medical treatment decisions for patients; medical testing services for testing biological specimens for the presence of biomarkers to assist in assessing the likelihood of malignancy for diagnostic or treatment purposes;  Assay development and validation for biomarkers, testing, kitting and sample storage, and diagnostic commercialization.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 15, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 10, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 9, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 9, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 9, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 24, 2026IUAFUSE AMENDMENT FILED—
Feb 24, 2026EXT1SOU EXTENSION 1 FILED—
Feb 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 2, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 2025DOCKASSIGNED TO EXAMINER—
Apr 27, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance